A Free Service Provided By



Legal Topics

Arbitration and Mediation
Car Accidents
Child Support
Child Custody & Visitation

Copyright Law
Criminal Law
Dangerous Drugs
DUI Drunk Driving

Elderly Laws
Employees' Rights
Estate Planning
Family Law
Immigration Law

Lemon Law
Medical Malpractice
Megan's Law
Mesothelioma & Asbestos

Probate & Estates
Product Recalls
Real Estate

Statute of Limitations

Taxes & the IRS
Traffic Violations
Workers' Compensation
Work Related Injury

Privacy Policy

Contact Us

About Us

Facts - Books - News    U.S. Facts Of Law:

Vioxx, FDA Health Advisory - Sept 30, 2004

On September 30, 2004, and FDA Health Advisory was issued announcing that Merck was announcing a voluntary withdrawal of Vioxx from the market due to safety concerns.  Vioxx was a commonly prescribed drug in the non-steroidal anti-inflammatory drug (NSAID) family.  It was approved by the FDA in 1999 for the management of pain and inflammation and was widely prescribed to arthritis sufferers.

A long term study of Vioxx on patients suffering from recurrent colon polyps was stopped early in September 2004 for safety reasons.  Subjects of the study using Vioxx showed an increased risk of heart attack and stroke compared to subjects taking a placebo.  Merck voluntarily pulled Vioxx from the market on September 30th.


Vioxx FDA Health Advisory Best Sellers from

(no title)


Newsfeed display by CaRP

Vioxx FDA Health Advisory News
GN News

This RSS Feed URL Is Deprecated
This RSS feed URL is deprecated, please update. New URLs can be found in the footers at

Neurology News LWW Journals Blog
Neurology News LWW Journals blog Since its publication in 2006, the US Food and Drug Administration FDA advisory against coprescription of triptans and selective serotonin reuptake inhibitors SSRI or selective norepinephrine reuptake inhibitors SNRI because of elevated risk of

Failure To Warn: Hundreds Died While Taking An Arthritis Drug, But Nobody Ale...
STAT Failure to warn: Hundreds died while taking an arthritis drug, but nobody alerted patients STAT In 2008, when FDA scientific advisers met at a Silver Spring, Md., hotel near the agency39s headquarters to debate whether to recommend approval of Actemra, they were haunted by a notorious error just a few years earlier. Vioxx, another arthritis drug

Failure To Warn: An Early Warning System For Drug Risks Falls Flat STAT
STAT Failure to warn: An early warning system for drug risks falls flat STAT Vioxx rofecoxib, made by Merck, had caused an estimated 88,000 heart attacks and 38,000 deaths, according to the journal the Lancet 9. Ketek telithromycin, linked to severe liver damage, was said by congressional investigators to have been approved

The Pharmaceutical Industry Is No Stranger To Fake News STAT
STAT The pharmaceutical industry is no stranger to fake news STAT As a way to defend industry from government regulation, corporate advocates routinely referred to studies published in Regulatory Toxicology and Pharmacology 17, the official journal of the International Society of Regulatory Toxicology and

IMPORTANT NOTICE: This webpage is Copyrighted content.  No portion of this page may be copied to any other webpage, forum, blog or other domain page or offline publication without written permission from Violators will be prosecuted to the fullest extent of the law.

The information provided by does not constitute legal advice or any other type of advice and is provided for educational purposes only without warranty of any kind. has not reviewed the information on this page for accuracy and is not responsible for any errors, omissions or inaccuracies.  For legal advice you should consult a licensed attorney.


Copyright All Rights Reserved -
No Portion of This Page May Be Copied Without Written Permission

Facts of Law about the vioxx fda health advisory

Facts of Law - Vioxx FDA Health Advisory